HPR164 Prices And Reimbursement Conditions for Poly (ADP-RIBOSE) Polymerase Inhibitors (PARPi) Indicated for Ovarian Cancer in Spain
Abstract
Authors
Almudena González Domínguez Ana María Durán Esteban María Merino Alexandra Ivanova